Published in Postgrad Med J on October 01, 1970
Use and control of cephalosporins. J Clin Pathol (1971) 5.12
Acute renal failure. Can Med Assoc J (1974) 0.84
Renal handling and lymph concentration of two cephalosporin analogues, cephacetrile and cephaloridine: an experimental study in dogs. Antimicrob Agents Chemother (1973) 0.75
Editorial: Confusion amongst the cephalosporins. Can Med Assoc J (1976) 0.75
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature (1986) 14.34
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84
A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes. Nature (1986) 8.64
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science (1994) 7.60
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.89
Antihypertensive effect of the oral angiotensin converting-enzyme inhibitor SQ 14225 in man. N Engl J Med (1978) 5.04
Transcriptional repression mediated by repositioning of genes to the nuclear lamina. Nature (2008) 4.92
Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science (2000) 4.53
Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med (2001) 4.39
Monitoring adverse reactions to new drugs: "restricted release" or "monitored release"? Br Med J (1977) 4.20
Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev (1995) 3.81
Cloning of a lymphoid-specific cDNA encoding a protein binding the regulatory octamer DNA motif. Science (1988) 3.01
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
Postmarketing surveillance of the safety of cimetidine: 12 month mortality report. Br Med J (Clin Res Ed) (1983) 2.90
A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet (1977) 2.90
Acute interstitial nephritis due to drugs: Review of the literature with a report of nine cases. Ann Intern Med (1980) 2.78
Analgesic nephropathy: clinical syndrome and prognosis. Br Med J (1971) 2.77
GPU-based streaming architectures for fast cone-beam CT image reconstruction and demons deformable registration. Phys Med Biol (2007) 2.72
Post marketing surveillance of captopril (for hypertension): a preliminary report. Br J Clin Pharmacol (1987) 2.56
Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics (2001) 2.50
Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev (1996) 2.43
Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. Br Med J (Clin Res Ed) (1982) 2.40
Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann Intern Med (1979) 2.31
Ventilatory effects of laparoscopy under general anaesthesia. Br J Anaesth (1992) 2.30
A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes. Mol Cell Biol (1990) 2.22
Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am J Pathol (2001) 2.21
Natural history of congenital kyphosis and kyphoscoliosis. A study of one hundred and twelve patients. J Bone Joint Surg Am (1999) 2.10
PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer. Mol Cell Biol (1993) 2.08
Post-marketing surveillance of the safety of cimetidine: twelve-month morbidity report. Q J Med (1985) 2.07
Cardioprotective potential of angiotensin converting enzyme inhibitors. J Hypertens (1991) 2.06
Familial colorectal cancer risk by subsite of primary cancer: a population-based study in Utah. Aliment Pharmacol Ther (2015) 2.03
Choice of toothbrush: a survey of dentists' personal preferences and recommendations for patients. Aust Dent J (1992) 2.02
The yellow card: mark II. BMJ (1990) 2.00
Antihypertensive effect of the new oral angiotensin converting enzyme inhibitor "MK-421". Lancet (1981) 1.99
Improvement of chronic congestive heart-failure by oral captopril. Lancet (1979) 1.94
Death from thyrotoxicosis. Lancet (1973) 1.93
Flat Refractive Geometry. IEEE Trans Pattern Anal Mach Intell (2011) 1.90
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. Br J Clin Pharmacol (1981) 1.88
Three new long-acting converting-enzyme inhibitors: relationship between plasma converting-enzyme activity and response to angiotensin I. Clin Pharmacol Ther (1981) 1.88
Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull (1990) 1.84
PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J (1998) 1.84
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril. Hypertension (1980) 1.81
Postmarketing surveillance of the safety of cimetidine: mortality during second, third, and fourth years of follow up. Br Med J (Clin Res Ed) (1985) 1.78
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Benzodiazepine drugs in general medical patients. Br Med J (1976) 1.74
Electron tomography of ice-embedded prokaryotic cells. Biophys J (1998) 1.73
PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity (1995) 1.72
Phototherapy induced hypocalcemia. Indian Pediatr (1998) 1.72
Methods of forced diuresis and its application in barbiturate poisoning. Lancet (1967) 1.71
Electroencephalographic bispectral index correlates with intraoperative recall and depth of propofol-induced sedation. Anesth Analg (1997) 1.71
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut (2000) 1.69
Kaposi's sarcoma in mainland Tanzania: a report of 117 cases. Br J Cancer (1969) 1.67
Renin and acute renal failure: studies in man. Br Med J (1970) 1.66
PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity (1997) 1.64
The effect of retrobulbar anesthesia on visual acuity in planned extracapsular cataract extraction. Ophthalmic Surg (1991) 1.64
Anesthetic potency (MAC) is independent of forebrain structures in the rat. Anesthesiology (1993) 1.62
Relative nephrotoxicity of cephalosporin antibiotics in an animal model. Can Med Assoc J (1972) 1.61
Adverse reactions to potassium chloride. Q J Med (1974) 1.60
Incorporation of 33P in soybean phosphatides. Biochim Biophys Acta (1970) 1.59
Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J (1999) 1.56
Detection of drug-induced disease. Br J Clin Pharmacol (1979) 1.56
Fatal pancytopenia associated with the use of captopril. Ann Intern Med (1981) 1.54
A retrospective audit of long-term lower limb complications following leg vein harvesting for coronary artery bypass grafting. Eur J Cardiothorac Surg (2003) 1.54
Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol (1983) 1.54
Mineralocorticoid-induced hypertension in patients with orthostatic hypotension. N Engl J Med (1979) 1.53
Blood loss in the Kolff twin-coil artificial kidney. Nephron (1970) 1.50
The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases. N Engl J Med (1988) 1.49
Measurement of body water and intracellular electrolytes by means of muscle biopsy. Lancet (1967) 1.48
One more use of ultrasound in ICU. Anaesthesia (2006) 1.48
Effect of furosemide on antibiotic-induced renal damage in rats. J Infect Dis (1972) 1.46
Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest (1982) 1.46
The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review. Diabet Med (2012) 1.44
Intranasal nitroglycerin and intraocular pressure during general anesthesia. Anesth Analg (1988) 1.43
HTF4: a new human helix-loop-helix protein. Nucleic Acids Res (1991) 1.43
Rat bite as a cause of diabetic foot ulcer--a series of eight cases. Diabetologia (2006) 1.41
Models of experimental hypertension in mice. Hypertension (1996) 1.41
Transcription factors in lymphocyte development--T and B cells get together. Cell (1999) 1.41
Venous thrombosis associated with the placement of peripherally inserted central catheters. J Vasc Interv Radiol (2001) 1.40
Muscle glycogenolysis during exercise: dual control by epinephrine and contractions. Am J Physiol (1982) 1.40
Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy. Hypertension (1995) 1.40
Symptomatic extreme bradycardia in obstructive jaundice. J Assoc Physicians India (1989) 1.39
Profile of young acute myocardial infarction in Harayana. J Assoc Physicians India (1998) 1.39
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Modern prophylactic treatment of animal bite cases. J Indian Med Assoc (1993) 1.38
Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood (2001) 1.38
Acute renal failure, tubular necrosis, and myocardial infarction induced in the rabbit by intravenous angiotensin II. Lancet (1971) 1.37
Ataxia telangiectasia. J Assoc Physicians India (1991) 1.37
Conjugation in archaea: frequent occurrence of conjugative plasmids in Sulfolobus. Plasmid (1998) 1.37
Electroencephalogram bispectral analysis predicts the depth of midazolam-induced sedation. Anesthesiology (1996) 1.36
The Arden grating acuity: effect of age and optical factors in the normal patient, with prediction of the false negative rate in screening for glaucoma. Br J Ophthalmol (1981) 1.35